EVALUATION OF THE OCCURRENCE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS AFTER SARS-COV-2 INFECTION

Authors

  • Jesse Leonie Koning Universidade CEUMA
  • Warlison Felipe Silva Saminez
  • Amanda Silva Santos Aliança

DOI:

https://doi.org/10.47820/recima21.v2i9.720

Keywords:

Covid-19 is a respiratory disease caused by SARS-CoV-2, transmitted

Abstract

Covid-19 is a respiratory disease caused by SARS-CoV-2, transmitted by inhalation of droplets released through coughing or sneezing, which occurs through contact with contaminated oral, nasal and ocular mucous membranes. People contaminated with Coronavirus (HcoV) usually develop signs and symptoms, including mild respiratory problems and persistent fever, an average of 5 to 6 days after infection. The infection occurs through the lytic infection of oligodendrocytes, damaging the myelin sheath of neurons. Demyelination can initiate a disease called Acute Disseminated Encephalomyelitis (hereinafter: ADEM), which is an autoimmune disease, a rare diffuse inflammatory disease of CNS.  It is a monophasic disease, characterized by a generalized attack, most notably the white matter of the brain and spinal cord, which damages the myelin, which is a protective layer of nerve fibers, and can cause serious neurological sequelae if not identified and treated early. The main neurological symptoms found were changes in mental level, ranging from confusion to coma, ataxia and focal motor deficits, in addition to symptoms of severe acute respiratory syndrome. In view of these considerations, this study aimed to evaluate the appearance of ADEM after Sars-coV-2 virus infection. For this, a literature review was carried out with a descriptive approach about the occurrence of ADEM, the bibliographic survey was carried out through a search in the scientific databases: GOOGLE ACADEMICS, SCIENCEDIRECT SPRINGER, Medical Publisher (hereinafter: PUBMED), and SCIELO, collecting articles, theses and books between the years 2018 and 2021, in English and Portuguese.

Downloads

Download data is not yet available.

References

De Brito WGF, Da Silva JPDO. Impactos neuropatológicos do COVID-19. Brazilian Journal of Health Review, 2020; 3 (3): 4227-4235.

Alencar DC et al. Busca de informações sobre o novo coronavírus no Brasil: uma análise da tendência considerando as buscas online. Acta Paulista de Enfermagem, 2020; 33.

Lima CMAO. Informações sobre o novo coronavírus (COVID-19). Radiol Bras., 2020; 53 (2):V–VI.

ABCMED, 2021. Encefalomielite disseminada aguda (ADEM) - entenda essa doença desmielinizante. 2021 [Acesso em 24 ago 2021]. Disponível em: https://www.abc.med.br/p/sinais.-sintomas-e-doencas/1390055/encefalomielite-disseminada-aguda-adem-entenda-essa-doenca-desmielinizante.htm

Mccuddy M et al. Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 Infection: A Case Series. MedRxiv, 2020.

Carmona C, Sousa S, Miranda M. Manifestações Neurológicas da COVID-19. Lusiadas Scientific Journal, 2021; 2 (1): 23-28.

Accorsi DX et al. COVID-19 e o Sistema Nervoso Central. Ulakes Journal of Medicine, t al. ULAKES J Med, 2020; 1 (EE): 81-87.

Zhang T, Rodricks MB, Hirsh E. COVID-19-associated acute disseminated encephalomyelitis: a case report. MedRxiv, 2020.

De Souza Gomes A, De Medeiros Filho OB, De Sousa MNA. Associação entre o COVID-19 e manifestações neurológicas. Brazilian Journal of Development, 2020; 6 (11): 8950-88961.

Novi G et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurology-Neuroimmunology Neuroinflammation, 2020; 7 (5).

Neppala S et al. COVID-19-Associated Familial Acute Disseminated Encephalomyelitis (ADEM); A Case report. IDCases, 2021; 26: e01264.

Mao L et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 2020; 77 (6): 683-690.

Utukuri PS et al. Possible acute disseminated encephalomyelitis related to severe acute respiratory syndrome coronavirus 2 infection. American Journal of Neuroradiology, 2020.

Pohl D et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology, 2016; 87 (9 S2): S38-S45.

Cole J et al. Acute disseminated encephalomyelitis in children: an updated review based on current diagnostic criteria. Pediatric neurology, 2019; 100: 26-34.

Reichard RR et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta neuropathologica, 2020; 140 (1): 1-6.

LOPES, Cesar Castello Branco et al. Acute Disseminated Encephalomyelitis in COVID-19: presentation of two cases and review of the literature. Arquivos de Neuro-Psiquiatria, 2020; n. AHEAD.

Mehta P et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet, 2020; 395 (10229): 1033-1034.

Caso F et al. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?. Autoimmunity reviews, 2020; 19 (5): 102524.

Panciani PP et al. SARS-CoV-2:“Three-steps” infection model and CSF diagnostic implication. Brain, behavior, and immunity, 2020; 87: 128.

Published

15/10/2021

How to Cite

Koning, J. L., Silva Saminez, W. F. ., & Silva Santos Aliança, A. (2021). EVALUATION OF THE OCCURRENCE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS AFTER SARS-COV-2 INFECTION. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 2(9), e29720. https://doi.org/10.47820/recima21.v2i9.720